Cargando…
Stem Cell Based Therapy Option in COVID-19: Is It Really Promising?
The COVID-19 patients were first detected in China, in December 2019, then the novel virus with associated pneumonia and other diseases spread quickly to worldwide becoming a serious public health intimidation. Despite all the efforts, the pharmacological agents used for controlling or treating the...
Autores principales: | Irmak, Duygu Koyuncu, Darıcı, Hakan, Karaöz, Erdal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
JKL International LLC
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7505270/ https://www.ncbi.nlm.nih.gov/pubmed/33014531 http://dx.doi.org/10.14336/AD.2020.0608 |
Ejemplares similares
-
The promising effects of BMP2 transfected mesenchymal stem cells on human osteosarcoma
por: SARI, Ahmet Sinan, et al.
Publicado: (2021) -
Shared Fate of Meningeal Mast Cells and Sensory Neurons in Migraine
por: Koyuncu Irmak, Duygu, et al.
Publicado: (2019) -
The Systematic Effect of Mesenchymal Stem Cell Therapy in Critical
COVID-19 Patients: A Prospective Double Controlled Trial
por: Adas, G, et al.
Publicado: (2021) -
Generation of Induced Pluripotent Stem Cells from Patients with Multiple Myeloma
por: Yılmaz Başaran, İrem, et al.
Publicado: (2021) -
Differentiation Potential and Tumorigenic Risk of Rat Bone Marrow Stem Cells Are Affected By Long-Term In Vitro Expansion
por: Karaöz, Erdal, et al.
Publicado: (2019)